Please assess the completion status of the following clinical trial:

Trial Title: Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Prediabetic, defined as 2-hour post-load serum glucose between 140 and 199 mg/dl on a 75-gram standard oral glucose tolerance test (OGTT) within the past 90 days~* Family history of type 2 diabetes mellitus~* Body mass index (BMI) between 25 and 35 kg/m2~* English speaker~* Nonsmoker~Exclusion Criteria:~* History of Axis I mood, anxiety, or psychotic disorder, confirmed by Structured Clinical Interview for DSM-IV~* Use of psychotropic drugs

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Aripiprazole (Type: ACTIVE_COMPARATOR): Participants will receive an injection of aripiprazole during the tracer-clamp study.
- Olanzapine (Type: ACTIVE_COMPARATOR): Participants will receive an injection of olanzapine during the tracer-clamp study.

Based on this trial design, predict the completion outcome and termination type (if applicable).